Hindustan Times Leadership Summit 2020. Pune-based drug maker signed a deal with British-Swedish company AstraZeneca to manufacture COVID-19 vaccine candidate, developed by the University of Oxford.
The final stage of the clinical trial of Oxford's COVID-19 vaccine has already started in the country.The drugmaker may apply for the emergency authorisation of Oxford COVID-19 vaccine in India.
Then COVID-19 vaccine will be available by December for essential workers, said Poonawalla. However, the decision will depend on the trial result, said the CEO, Serum Institute of India.
Read more on livemint.com